Bora Pharmaceuticals Co., LTD. (TPE:6472)
Taiwan
· Delayed Price · Currency is TWD 733.00
+25.00 (3.53%)
May 14, 2025, 1:30 PM CST
TPE:6472 Revenue
Bora Pharmaceuticals Co., LTD. had revenue of 4.48B TWD in the quarter ending March 31, 2025, with 56.77% growth. This brings the company's revenue in the last twelve months to 20.87B, up 69.98% year-over-year. In the year 2024, Bora Pharmaceuticals Co., LTD. had annual revenue of 19.25B with 35.53% growth.
Revenue (ttm)
20.87B
Revenue Growth
+69.98%
P/S Ratio
3.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
75.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.25B | 5.05B | 35.53% |
| Dec 31, 2023 | 14.20B | 3.71B | 35.31% |
| Dec 31, 2022 | 10.49B | 5.59B | 114.18% |
| Dec 31, 2021 | 4.90B | 3.10B | 172.28% |
| Dec 31, 2020 | 1.80B | 270.35M | 17.68% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.33M |
| Pegavision | 6.69B |
| Lumosa Therapeutics | 43.59M |
| Center Laboratories | 1.63B |